| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
The primary goal of AI in medical imaging is to improve diagnostic accuracy and patient outcomes. By leveraging AI algorithms, healthcare professionals can detect diseases earlier, identify subtle patterns in medical images, and make more informed decisions about treatment. |
Ultimately, AI in medical imaging enhances the capabilities of healthcare providers, increases efficiency, and helps deliver more accurate diagnoses. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
a key benefit of AI in radiology noted in the article. AI systems can analyze medical images independently and provide additional insights, serving as a second layer of review |
AI's role as a second opinion strengthens the diagnostic process and supports radiologists in making more accurate assessments. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
According to the article, AI literacy refers to the understanding and familiarity with AI technologies, their applications, and their implications, especially within the context of healthcare and medical fields like radiology |
Ultimately, AI literacy ensures that medical professionals can use AI systems safely, ethically, and effectively while maximizing their benefits for patient care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
The color of the AI machines is not listed as a factor influencing the acceptability of AI among healthcare professionals.
Factors that are typically cited as influencing acceptability |
The appearance or color of the AI machines is not a significant factor in the acceptance of AI in healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
social influence plays a significant role in AI acceptability in healthcare by affecting healthcare professionals’ decisions to use AI. Social influence can come from various sources |
In essence, social influence can shape how healthcare professionals perceive AI's value, its legitimacy, and its potential for improving patient care, affecting their willingness to adopt and integrate it into their practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
None of the above |
|
It's an advantage but not the best. |
AI usage in healthcare |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Ensuring AI systems have high algorithmic performance |
|
ensuring AI systems have high algorithmic performance is essential for increasing AI acceptability among medical professionals. If AI systems consistently provide accurate, reliable, and clinically relevant results, healthcare professionals are more likely to trust and use them. High algorithmic performance |
When AI systems perform well and demonstrate their effectiveness in real-world medical settings, healthcare professionals are more likely to accept them and integrate them into their daily practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
|
|
The 'system usage' category of AI acceptability factors includes factors like value proposition and integration with workflows |
These factors are crucial for determining whether healthcare professionals will see AI as a useful and practical tool in their work, contributing to its overall acceptability in the field. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
|
|
ethicality significantly impacts AI acceptability among healthcare professionals, as it affects views on AI based on compatibility with professional values. Healthcare professionals are more likely to accept AI if they believe that the technology aligns with ethical standards |
If AI systems are seen as ethical and aligned with the core values of the medical profession, healthcare professionals are more likely to trust and accept them for use in clinical practice. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
|
|
the article emphasized considering user experience and system integration deeply as a crucial methodological approach for future AI acceptability studies |
By deeply considering these factors, future studies can provide more comprehensive insights into the practical aspects of AI acceptability, leading to more successful and sustainable adoption of AI in healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Human embryonic stem cells have the potential to differentiate into dopamine-producing neurons, which can be transplanted into the brain to replace the lost or damaged neurons, restoring dopamine levels and improving motor function. This approach holds promise for providing long-term relief or even potentially reversing some aspects of the disease. |
Parkinson’s disease is characterized by the degeneration of dopamine-producing neurons in the brain, which leads to motor symptoms like tremors, rigidity, and bradykinesia (slowness of movement). |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Non-human primates are often used in preclinical studies for their physiological and neurological similarities to humans, making them valuable models for testing treatments like stem cell therapies for diseases such as Parkinson's. These studies help researchers evaluate the safety, potential side effects, and efficacy of the treatment before moving on to human clinical trials. |
STEM-PD product |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
This study was conducted to assess the safety and potential risks of the STEM-PD product before proceeding to larger animal models and human trials. |
It helped researchers understand how the treatment might behave in a living organism, including any adverse effects, and ensured the product’s safety profile. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I |
|
clinical trials are typically conducted to evaluate the safety, tolerability, and dosing of a new treatment in a small group of healthy volunteers or patients. For STEM-PD, this phase would focus on assessing the safety of the stem cell-based treatment for |
Parkinson's disease in human subjects before progressing to later trial phases that focus more on efficacy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
|
|
manufactured using spontaneous differentiation. This process involves taking human embryonic stem cells (hESCs) and allowing them to differentiate naturally into dopamine-producing neurons without the need for external signaling factors or complex manipulation. The goal is to generate a population of neurons that can replace the lost dopamine neurons in Parkinson's disease patients. |
differentiation is a more straightforward approach compared to other methods that require more controlled or directed differentiation, making it a potentially cost-effective and scalable option for producing the required cells for therapy. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
|
|
there were no adverse effects or tumor formation observed during the preclinical safety study. This finding is significant because it indicates that the stem cell-based treatment did not cause harmful side effects or lead to the development of tumors |
which are important considerations in evaluating the safety of such therapies before progressing to clinical trials in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
the transplanted cells reversed motor deficits in rats. The study demonstrated that the stem cell-based treatment successfully improved motor function in the rats, which is a crucial outcome for testing the potential of STEM-PD in treating Parkinson's disease. |
This improvement suggests that the transplanted dopamine-producing neurons were effective in alleviating some of the symptoms of Parkinson's, such as tremors and motor impairment. This finding is an important step toward evaluating the therapy's potential for human use. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
SOX1 and PAX6 |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
play a crucial role in cell patterning for specific neural fates during the manufacturing process of STEM-PD. |
Together, these growth factors ensure that the stem cells differentiate in a controlled and directed way, ultimately producing the appropriate type of neurons that can be used for treating Parkinson’s disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Development of new cognitive abilities |
|
the recovery of motor function. The study focused on assessing whether the stem cell-based therapy could reverse motor deficits associated with Parkinson’s disease, such as tremors, rigidity, and impaired movement. |
The results indicated that the transplanted cells successfully improved motor function in the rats, suggesting that the therapy could potentially help replace the dopamine-producing neurons lost in Parkinson's disease and alleviate motor symptoms. This was a critical step in demonstrating the potential of STEM-PD for treating Parkinson's disease in humans. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|